Patents by Inventor Ira Schildkraut

Ira Schildkraut has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230022745
    Abstract: A method of labeling, and optionally enriching, for a population of target RNA molecules in a mixture of RNAs is provided. In some embodiments, the method may comprise (a) adding a label to the 5? end of 5?-diphosphorylated or 5?-triphosphorylated target RNA molecules in a sample by incubating the sample with labeled GTP and a capping enzyme; and (b) optionally enriching for target RNA comprising the affinity tag-labeled GMP using an affinity matrix that binds to the affinity tag. The label may be an oligonucleotide, which may further comprise an affinity group attached either internally or at 5? or 3? end of the oligonucleotide where the oligonucleotide label may be added directly, or indirectly via a reaction with a reactive group to the target RNA.
    Type: Application
    Filed: September 14, 2022
    Publication date: January 26, 2023
    Applicant: New England Biolabs, Inc.
    Inventors: Ira Schildkraut, Laurence Ettwiller, Ivan R. Correa, JR., George Tzertzinis, John Buswell, Madalee G. Wulf
  • Patent number: 11479766
    Abstract: A method of labeling, and optionally enriching, for a population of target RNA molecules in a mixture of RNAs is provided. In some embodiments, the method may comprise (a) adding a label to the 5? end of 5?-diphosphorylated or 5?-triphosphorylated target RNA molecules in a sample by incubating the sample with labeled GTP and a capping enzyme; and (b) optionally enriching for target RNA comprising the affinity tag-labeled GMP using an affinity matrix that binds to the affinity tag. The label may be an oligonucleotide, which may further comprise an affinity group attached either internally or at 5? or 3? end of the oligonucleotide where the oligonucleotide label may be added directly, or indirectly via a reaction with a reactive group to the target RNA.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: October 25, 2022
    Assignee: New England Biolabs, Inc.
    Inventors: Ira Schildkraut, Laurence Ettwiller, Ivan R. Correa, Jr., George Tzertzinis, John Buswell, Madalee G. Wulf
  • Patent number: 11225658
    Abstract: Provided herein is a method for making an cDNA library, comprising adding an affinity tag-labeled GMP to the 5? end of targeted RNA species in a sample by optionally decapping followed by incubating the sample with an affinity tag-labeled GTP and a capping enzyme, enriching for RNA comprising the affinity tag-labeled GMP using an affinity matrix that binds to the affinity tag, reverse transcribing the enriched RNA to produce a population of cDNAs, and adding a tail to the 3? end of the population of cDNAs using a terminal transferase, to produce an cDNA library.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: January 18, 2022
    Assignee: New England Biolabs, Inc.
    Inventors: Bo Yan, Laurence Ettwiller, Ira Schildkraut, George Tzertzinis, Ivan R. Correa, Jr., Nan Dai, Madalee G. Wulf
  • Patent number: 10428368
    Abstract: A method of enriching for a population of RNA molecules in a mixture of RNAs is provided. In some embodiments, the method may comprise (a) adding an affinity tag to the 5? end of 5?-diphosphorylated or 5?-triphosphorylated RNA molecules in a sample by incubating the sample with an affinity tag-labeled GTP and a capping enzyme; and (b) enriching for RNA comprising the affinity tag-labeled GMP using an affinity matrix that binds to the affinity tag.
    Type: Grant
    Filed: April 25, 2016
    Date of Patent: October 1, 2019
    Assignee: New England Biolabs, Inc.
    Inventors: Ira Schildkraut, Laurence Ettwiller, Ivan R. Correa, Jr., Michael Sproviero
  • Publication number: 20180195061
    Abstract: A method of labeling, and optionally enriching, for a population of target RNA molecules in a mixture of RNAs is provided. In some embodiments, the method may comprise (a) adding a label to the 5? end of 5?-diphosphorylated or 5?-triphosphorylated target RNA molecules in a sample by incubating the sample with labeled GTP and a capping enzyme; and (b) optionally enriching for target RNA comprising the affinity tag-labeled GMP using an affinity matrix that binds to the affinity tag. The label may be an oligonucleotide, which may further comprise an affinity group attached either internally or at 5? or 3? end of the oligonucleotide where the oligonucleotide label may be added directly, or indirectly via a reaction with a reactive group to the target RNA.
    Type: Application
    Filed: February 28, 2018
    Publication date: July 12, 2018
    Applicant: New England Biolabs, Inc.
    Inventors: Ira Schildkraut, Laurence Ettwiller, Ivan R. Correa, Jr., George Tzertzinis, John Buswell, Madalee G. Wulf
  • Publication number: 20180030436
    Abstract: Provided herein is a method for making an cDNA library, comprising adding an affinity tag-labeled GMP to the 5? end of targeted RNA species in a sample by optionally decapping followed by incubating the sample with an affinity tag-labeled GTP and a capping enzyme, enriching for RNA comprising the affinity tag-labeled GMP using an affinity matrix that binds to the affinity tag, reverse transcribing the enriched RNA to produce a population of cDNAs, and adding a tail to the 3? end of the population of cDNAs using a terminal transferase, to produce an cDNA library.
    Type: Application
    Filed: October 17, 2017
    Publication date: February 1, 2018
    Applicant: New England Biolabs, Inc.
    Inventors: Bo Yan, Laurence Ettwiller, Ira Schildkraut, George Tzertzinis, Ivan R. Correa, JR., Nan Dai, Madalee G. Wulf
  • Publication number: 20170253911
    Abstract: A method of enriching for a population of RNA molecules in a mixture of RNAs is provided. In some embodiments, the method may comprise (a) adding an affinity tag to the 5? end of 5?-diphosphorylated or 5?-triphosphorylated RNA molecules in a sample by incubating the sample with an affinity tag-labeled GTP and a capping enzyme; and (b) enriching for RNA comprising the affinity tag-labeled GMP using an affinity matrix that binds to the affinity tag.
    Type: Application
    Filed: April 25, 2016
    Publication date: September 7, 2017
    Applicant: New England Biolabs, Inc.
    Inventors: Ira Schildkraut, Laurence Ettwiller, Ivan R. Correa, Jr., Michael Sproviero
  • Patent number: 8486666
    Abstract: Methods and compositions are provided for efficiently removing a guanine cap from the 5? end of an RNA using enzymes. Decapped RNA can be used for cloning, sequencing or other RNA manipulations.
    Type: Grant
    Filed: September 26, 2011
    Date of Patent: July 16, 2013
    Assignee: New England Biolabs, Inc.
    Inventor: Ira Schildkraut
  • Publication number: 20120077230
    Abstract: Methods and compositions are provided for efficiently removing a guanine cap from the 5? end of an RNA using enzymes. Decapped RNA can be used for cloning, sequencing or other RNA manipulations.
    Type: Application
    Filed: September 26, 2011
    Publication date: March 29, 2012
    Applicant: NEW ENGLAND BIOLABS, INC.
    Inventor: Ira Schildkraut
  • Publication number: 20090142811
    Abstract: Compositions that describe a thermostable DNA ligase isolated from Thermococcus sp. (strain 9° N-7) and methods for making und using the same are described. The thermostable DMA ligase depends on ATP and not NAD+ as a cofactor during ligation, and retains activity at 100° C.
    Type: Application
    Filed: September 15, 2006
    Publication date: June 4, 2009
    Applicant: New England Biolabs, Inc.
    Inventors: Ira Schildkraut, Ezra Schildkraut
  • Publication number: 20050042619
    Abstract: The present invention relates to the use of site-specific nucleic acid nicking enzymes to create single-stranded regions in duplex nucleic acids. Such single-stranded regions can take the form of gaps interior to the duplex, or terminal single-stranded regions. Single-stranded termini can be crafted to allow linkage of various elements via base-pairing with elements containing a complementary single-stranded region. This joining is useful, for example, in an ordered, oriented assembly of DNA modules to create cloning or expression vectors. This joining is also useful in attaching detection probes and purifying DNA molecules containing the single-stranded region. Gaps are useful in similar applications, including attaching detection or purification probes.
    Type: Application
    Filed: September 8, 2003
    Publication date: February 24, 2005
    Inventors: William Jack, Ira Schildkraut, Julie Menin
  • Patent number: 6660475
    Abstract: The present invention relates to the use of site-specific nucleic acid nicking enzymes to create single-stranded regions in duplex nucleic acids. Such single-stranded regions can take the form of gaps interior to the duplex, or terminal single-stranded regions. Single-stranded termini can be crafted to allow linkage of various elements via base-pairing with elements containing a complementary single-stranded region. This joining is useful, for example, in an ordered, oriented assembly of DNA modules to create cloning or expression vectors. This joining is also useful in attaching detection probes and purifying DNA molecules containing the single-stranded region. Gaps are useful in similar applications, including attaching detection or purification probes.
    Type: Grant
    Filed: December 15, 2000
    Date of Patent: December 9, 2003
    Assignee: New England Biolabs, Inc.
    Inventors: William E. Jack, Ira Schildkraut, Julie Forney Menin
  • Publication number: 20030211506
    Abstract: The present invention relates to recombinant DNA which encodes a novel nicking endonuclease, N.BstNBI, and the production of N.BstNBI restriction endonuclease from the recombinant DNA utilizing PleI modification methylase. Related expression vectors, as well as the application of N.BstNBI and other nicking enzymes in non-modified strand displacement amplification, is disclosed also.
    Type: Application
    Filed: November 14, 2002
    Publication date: November 13, 2003
    Inventors: Huimin Kong, Lauren Sears Higgins, Michael A Dalton, Rebecca B Kucera, Ira Schildkraut, Geoffrey G Wilson
  • Publication number: 20030022317
    Abstract: The present invention relates to the use of site-specific nucleic acid nicking enzymes to create single-stranded regions in duplex nucleic acids. Such single-stranded regions can take the form of gaps interior to the duplex, or terminal single-stranded regions. Single-stranded termini can be crafted to allow linkage of various elements via base-pairing with elements containing a complementary single-stranded region. This joining is useful, for example, in an ordered, oriented assembly of DNA modules to create cloning or expression vectors. This joining is also useful in attaching detection probes and purifying DNA molecules containing the single-stranded region. Gaps are useful in similar applications, including attaching detection or purification probes.
    Type: Application
    Filed: December 15, 2000
    Publication date: January 30, 2003
    Applicant: New England Biolabs, Inc.
    Inventors: William E. Jack, Ira Schildkraut, Julie Forney Menin
  • Patent number: 6191267
    Abstract: The present invention relates to recombinant DNA which encodes a novel nicking endonuclease, N.BstNBI, and the production of N.BstNBI restriction endonuclease from the recombinant DNA utilizing PleI modification methylase. Related expression vectors, as well as the application of N.BstNBI in non-thio strand displacement amplification, is disclosed also.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: February 20, 2001
    Assignee: New England Biolabs, Inc.
    Inventors: Huimin Kong, Lauren S. Higgins, Michael Dalton, Rebecca B. Kucera, Ira Schildkraut
  • Patent number: 5200336
    Abstract: The present invention provides a novel Type II restriction endonuclease obtainable from Bacillus coagulans. The endonuclease known as Bcg I, recognizes the following nucleotide sequence and has a cleavage point at both ends outside of its recognition sequence: ##STR1## to produce a 34 base pair fragment. Also described is a process for obtaining purified Bcg I from Bacillus coagulans, as well as processes for mapping chromosomal DNA and methods for reducing background in transformants with enzymes such as Bcg I.
    Type: Grant
    Filed: July 2, 1990
    Date of Patent: April 6, 1993
    Assignee: New England Biolabs, Inc.
    Inventors: Huimin Kong, Ira Schildkraut